Transactions: Sweden
Filter

Secondary placing of shares in Recipharm (SE) — SEK 269 million


Acquisition of CDMO Lusomedicamenta Sociedade Técnica Farmacêutica S.A. (PT) by Recipharm AB (SE) — Enterprise value SEK 1 billion

Initial public offering of Lifco (SE) on NASDAQ Stockholm – SEK 4.2 billion

Divestment of Apotek Hjärtat AB (SE) to ICA Gruppen (SE) by Altor (SE) — Enterprise value SEK 5.7 billion

Rights issue in Oasmia Pharmaceutical AB (SE) — SEK 176 million

Rights issue in Nickel Mountain Group AB (SE) — NOK 68 million

Initial public offering of Gränges (SE) on NASDAQ OMX Stockholm – SEK 2.2 billion

Divestment of Ipeer AB (SE) to TeliaSonera (SE) by the founding family (SE) — Amount not disclosed

Initial public offering of Inwido (SE) on NASDAQ OMX Stockholm – SEK 2.6 billion

Divestment of Nefab AB (SE) to the founding family (SE) by Nordic Capital (SE) — Amount not disclosed
